BMC Complementary and Alternative Medicine BioMed Central Open Access

First Page		Document Content
Date: 2014-12-05 00:43:28 Immunology Cytokines Immune system T cells Lymphocytes Natural killer cell Cancer immunotherapy Interleukin Carcinogenesis Biology Medicine Anatomy		BMC Complementary and Alternative Medicine BioMed Central Open Access Add to Reading List Source URL: fxzx.bjmu.edu.cn Download Document from Source Website File Size: 548,64 KB Share Document on Facebook

	# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,,#, Stephen M. Shaw 1,, Kim Wi DocID: 1vdls - View Document
	Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx DocID: 1uTyz - View Document
	FALL/WINTERUCSF Oncology Connection Oncologist Lawrence Fong, MD, is leading UCSF’s newly launched Cancer Immunotherapy Program DocID: 1tGAn - View Document
	Cancer Immunotherapy & Personalized Vaccines Alex Rubinsteyn Mount Sinai, Hammer Lab DocID: 1tBVB - View Document